Mirati Therapeutics (NASDAQ:MRTX) Coverage Initiated at StockNews.com
StockNews.com started coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a report published on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Other research analysts have also recently issued reports about the stock. Scotiabank upgraded shares of Mirati Therapeutics from an underperform rating to a sector perform […]
More Stories
Chicago Partners Investment Group LLC Sells 837 Shares of Guidewire Software, Inc. (NYSE:GWRE)
Chicago Partners Investment Group LLC decreased its position in shares of Guidewire Software, Inc. (NYSE:GWRE – Free Report) by 42.8%...
Chinese Stocks To Add to Your Watchlist – August 10th
Duolingo, Wynn Resorts, and Mettler-Toledo International are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool....
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Sold by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC cut its holdings in shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Free Report) by...
Fitness Stocks To Add to Your Watchlist – August 11th
Apple, Celsius, PDD, lululemon athletica, and Paychex are the five Fitness stocks to watch today, according to MarketBeat’s stock screener...
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Maryland State Retirement & Pension System
Maryland State Retirement & Pension System trimmed its stake in Natera, Inc. (NASDAQ:NTRA – Free Report) by 12.4% in the...
Deutsche Bank AG Cuts Stock Position in Sprouts Farmers Market, Inc. (NASDAQ:SFM)
Deutsche Bank AG trimmed its holdings in Sprouts Farmers Market, Inc. (NASDAQ:SFM – Free Report) by 24.3% during the 1st...